Search results
Results from the WOW.Com Content Network
Bayer Corporation (also known as Bayer USA) is the American subsidiary of Bayer AG. Its main offices are located in Whippany, New Jersey . In addition it has 40 fully consolidated subsidiary companies [ 3 ] located in 19 different states.
Also in 2002, Bayer AG acquired the Dutch seed company Nunhems, which at the time was one of the world's top five seed companies. [159] [160]: 270 In 2006, the U.S. Department of Agriculture announced that Bayer CropScience's LibertyLink genetically modified rice had contaminated the U.S. rice supply. Shortly after the public learned of the ...
Monsanto also became one of the most controversial large corporations in the world, over a range of issues involving its industrial and agricultural chemical products, and GM seed. [181] In April 2018, just prior to Bayer's acquisition, Bayer indicated that improving Monsanto's reputation represented a major challenge. [182]
Shares in Bayer dropped as much as 5.7% on Monday after the embattled German company was ordered to pay $2.25 billion in damages, the highest amount yet in its ongoing litigation linked to an ...
There’s no question Bayer needs reinvention. Its market cap has plunged to two-decade lows, in large part because of the massive litigation that came after its purchase of Monsanto in 2018.
DeKalb Genetics Corporation (often stylized DEKALB; formerly DeKalb Agricultural Association and DEKALB AgResearch) was a diversified company headquartered in DeKalb, Illinois that marketed agricultural seeds and other products. The company was best known for its leading role in the development of hybrid corn and for its "winged ear" logo.
Agricultural seeds and chemicals maker Bayer AG on Monday launched a digital farming platform that it says will help U.S. growers enact environmentally friendly practices and connect them with ...
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2]Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.